Health Enhancement Products, a health and wellness company developing natural bioactive compounds for use as dietary supplements and food ingredients, as well as biologics for medicinal and pharmaceutical applications in humans and animals, reports that it has entered into a collaborative/option agreement with a global animal health company. For competitive considerations and to protect the intellectual property of both parties, the name of the animal health company is being withheld.
HEPI will collaborate with scientists from the animal health company to move forward with validation and product development. The agreement provides for a licensing option covering bovine applications across a range of modalities, and includes HEPI's natural compound, the company's proprietary refined algal extract and the synthetic molecules.
Additional terms of the agreement call for pre-determined intervals of 90 days for an evaluation period and a negotiation period, which HEPI expects may result in a final licensing arrangement.
HEPI says that additional details may be released over the next few weeks.
For more information visit health-enhancement-products.com
QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net